Advertisement

A genetic variant c.553G>T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population

  • Yibo Tang
    Affiliations
    Atherosclerosis Research Center, Nanjing Medical University, No. 140 HanZhong Road, Nanjing 210029, China

    Key Laboratory of Human Functional Genomics, Jiangsu Province, Nanjing 210029, China
    Search for articles by this author
  • Ping Sun
    Affiliations
    Atherosclerosis Research Center, Nanjing Medical University, No. 140 HanZhong Road, Nanjing 210029, China
    Search for articles by this author
  • Dongping Guo
    Affiliations
    Atherosclerosis Research Center, Nanjing Medical University, No. 140 HanZhong Road, Nanjing 210029, China
    Search for articles by this author
  • Albert Ferro
    Affiliations
    Department of Clinical Pharmacology, GKT School of Medicine, King's College London, Guy's Hospital Campus, London SE1 1UL, UK
    Search for articles by this author
  • Yong Ji
    Affiliations
    Atherosclerosis Research Center, Nanjing Medical University, No. 140 HanZhong Road, Nanjing 210029, China

    Key Laboratory of Human Functional Genomics, Jiangsu Province, Nanjing 210029, China

    Department of Clinical Pharmacology, GKT School of Medicine, King's College London, Guy's Hospital Campus, London SE1 1UL, UK
    Search for articles by this author
  • Qi Chen
    Affiliations
    Atherosclerosis Research Center, Nanjing Medical University, No. 140 HanZhong Road, Nanjing 210029, China

    Key Laboratory of Human Functional Genomics, Jiangsu Province, Nanjing 210029, China
    Search for articles by this author
  • Leming Fan
    Correspondence
    Corresponding author. Tel.: +86 25 86862888; fax: +86 25 86508960.
    Affiliations
    Atherosclerosis Research Center, Nanjing Medical University, No. 140 HanZhong Road, Nanjing 210029, China

    Key Laboratory of Human Functional Genomics, Jiangsu Province, Nanjing 210029, China
    Search for articles by this author

      Abstract

      Elevation in plasma triglycerides (TG) has been widely accepted as a coronary artery disease (CAD) risk predictor. Recently, a new apolipoprotein playing an important role in TG metabolism named apolipoprotein AV (apoAV) was discovered, which is encoded by the APOA5 gene. Several single nucleotide polymorphisms (SNPs) of APOA5 associated with increased TG concentrations have been identified. We here report that a recently identified genetic variant, c.553G > T in the APOA5 gene which causes a substitution of a cysteine for a glycine residue at amino acid residue 185(G185C) is also associated with increased TG levels. To investigate the association between this genetic variation and the risk of CAD, a case-control study comprising 232 patients with CAD and 302 controls from the same area of China was performed. The minor allele frequencies of c.553G > T for the CAD and control groups were 7.76 and 3.97%, respectively (P = 0.008). In both the CAD and control groups, the T allele carriers had higher serum TG levels than homozygous carriers of the major G allele (CAD group: 2.67 ± 1.48 mmol/l versus 1.95 ± 1.02 mmol/l, P = 0.021; controls: 2.31 ± 1.20 mmol/l versus 1.68 ± 0.95 mmol/l, P = 0.002). After adjustment for age, gender, body mass index, smoking status, glucose and presence of hypertension, the odds ratio (OR) for CAD in the T allele carriers was 2.089 (95% CI = 1.140–3.830, P = 0.017), in comparison to the individuals without the T allele. These results suggest that the APOA5 c.553G > T polymorphism is an important predictor for hypertriglyceridemia and CAD.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Assmann G.
        • Schulte H.
        • Von Eckardstein A.
        Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men.
        Am J Cardiol. 1996; 77: 1179-1184
        • Austin M.A.
        • Hokanson J.E.
        • Edwards K.L.
        Hypertriglyceridemia as a cardiovascular risk factor.
        Am J Cardiol. 1998; 81: 7B-12B
        • Malloy M.J.
        • Kane J.P.
        A risk factor for atherosclerosis: triglyceride-rich lipoproteins.
        Adv Intern Med. 2001; 47: 111-136
        • Forester J.S.
        Triglycerides: risk factor or fellow traveler?.
        Curr Opin Cardiol. 2001; 16: 261-264
        • Brenn T.
        Genetic and environmental effects on coronary heart disease risk factors in northern Norway. The cardiovascular disease study in Finnmark.
        Ann Hum Genet. 1994; 58: 369-379
        • Peacock R.E.
        • Hamsten A.
        • Johansson J.
        Associations of genotypes at theapolipoprotein AI/CIII/AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses.
        Clin Genet. 1994; 46: 273-282
        • Ordovas J.M.
        • Civeira
        • et al.
        Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease.
        Atherosclerosis. 1991; 87: 75-86
        • Groenendijk M.
        • Cantor R.M.
        • et al.
        The apoAI-CIII-AIV gene cluster.
        Atherosclerosis. 2001; 157: 1-11
        • Pennacchio L.A.
        • Olivier M.
        • Hubacek J.A.
        • et al.
        An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.
        Science. 2001; 294: 169-173
        • Van der Vilet H.N.
        • Sammels M.G.
        • Leegwater A.C.
        • et al.
        Apolipoprotein AV: a novel apolipoprotein associated with a nearly phase of liver regeneration.
        J Biol Chem. 2001; 276: 44512-44520
        • Van der Vilet H.N.
        • Schaap F.G.
        • et al.
        Adenovirus overexpression of apolipoprotein A–V reduces serum levels of triglycerides and cholesterol in mice.
        Biochem Biophys Res Commun. 2002; 295: 1156-1159
        • Nabika T.
        • Nasreen S.
        • Kobayashi S.
        • et al.
        The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese.
        Atherosclerosis. 2002; 165: 201-204
        • Endo K.
        • Yanagi H.
        • Araki J.
        • et al.
        Association found between the promoter region polymorphism in the apolipoprotein A–V gene and the serum triglyceride level in Japanese school children.
        Hum Genet. 2002; 111: 570-572
        • Evans D.
        • Buchwald A.
        • Beil F.U.
        The single nucleotidepolymorphism −1131T > C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia.
        J Mol Med. 2003; 81: 645-654
        • Baum L.
        • Tomlinson B.
        • Thomas G.N.
        APOA5 −1131T > C polymorphism is associated with triglyceride levels in Chinese men.
        Clin Genet. 2003; 63: 377-379
        • Jang Y.
        • Kim J.Y.
        • Kim O.Y.
        • et al.
        The −1131T > C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men.
        Am J Clin Nutr. 2004; 80: 832-840
        • Kao J.T.
        • Wen H.C.
        • et al.
        A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia.
        Hum Mol Genet. 2003; 12: 2533-2539
        • Hubacek J.A.
        • Adamkova V.
        • et al.
        New variants in the apolipoprotein AV gene in individuals with extreme triglyceride levels.
        Physiol Res. 2004; 53: 225-228
        • Hokanson J.E.
        • Austin M.A.
        • et al.
        Plasma triglyceride levels is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.
        J Cardiovasc Risk. 1996; 3: 213-219
        • Jeppesen J.
        • Hein H.O.
        • et al.
        Triglyceride concentration and ischemic heart disease: an 8-year follow-up in the copenhagen male study.
        Circulation. 1998; 97: 1029-1036
        • Martin S.
        • Nicaud V.
        • Humphries S.E.
        • et al.
        Contribution of APOA5 gene variants to serum triglyceride determination and to the response to both fat and glucose tolerance challenges.
        Biochim Biophys Acta. 2003; 1637: 217-225
        • Lai C.Q.
        • Tai E.S.
        • Tan C.E.
        • et al.
        The apolipoprotein A5 locus is a strong determinant of serum triglyceride concentrations across ethnic groups in Singapore.
        J Lipid Res. 2003; 44: 2365-2373
        • Aouizerat B.E.
        • Kulkarni M.
        • Heilbron D.
        • et al.
        Genetic analysis of a polymorphism in the human apoA–V gene: effect on serum lipids.
        J Lipid Res. 2003; 44: 1167-1173
        • Talmud P.J.
        • Hawe E.
        • et al.
        Relative contribution of variation within the APO3/A4/A5 gene cluster in determining plasma triglycerides.
        Hum Mol Genet. 2002; 11: 3039-3046
        • Pennacchio L.A.
        • Rubin E.M.
        Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice.
        Arterioscler Thromb Vasc Biol. 2003; 23: 529-534
        • Weinberg R.B.
        • et al.
        Structure and interfacial properties of human apolipoprotein AV.
        J Biol Chem. 2003; 278: 34438-34444
        • Szalai C.
        • Keszei M.
        • et al.
        Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease.
        Atherosclerosis. 2004; 173: 109-114
        • Bi N.
        • Yan S.K.
        • Li G.P.
        • et al.
        A single nucleotide polymorphism −1131T > C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese.
        Mol Genet Metab. 2004; 83: 280-286
        • Lee K.W.
        • Ayyobi A.F.
        • et al.
        APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but it is not a risk factor for coronary artery disease.
        Atherosclerosis. 2004; 176: 165-172
        • Wong W.M.
        • Hawe E.
        • et al.
        Apolipoprotein AIV gene variant S347 is associated with increased risk of coronary heart disease and lower plasma apolipoprotein AIV levels.
        Circ Res. 2003; 92: 969-975